|
Volume 272, Number 11,
Issue of March 14, 1997
pp. 7506-7510
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Targeted Disruption of the Mouse Lecithin:Cholesterol
Acyltransferase (LCAT) Gene
GENERATION OF A NEW ANIMAL MODEL FOR HUMAN LCAT DEFICIENCY
(Received for publication, January 2, 1997)
Naohiko
Sakai
,
Boris L.
Vaisman
,
Christine A.
Koch
,
Robert F.
Hoyt
Jr.§
,
Susan M.
Meyn
,
Glenda D.
Talley
,
Jorge A.
Paiz
,
H. Bryan
Brewer
Jr.
and
Silvia
Santamarina-Fojo
From the Molecular Disease Branch and the § Laboratory
of Animal Medicine and Surgery, NHLBI, National Institutes of
Health, Bethesda, Maryland 20892-1666
We have established a mouse model for human LCAT
deficiency by performing targeted disruption of the LCAT gene in mouse
embryonic stem cells. Homozygous LCAT-deficient mice were healthy at
birth and fertile. Compared with age-matched wild-type littermates, the
LCAT activity in heterozygous and homozygous knockout mice was reduced
by 30 and 99%, respectively. LCAT deficiency resulted in significant
reductions in the plasma concentrations of total cholesterol, HDL
cholesterol, and apoA-I in both LCAT / mice (25, 7, and 12%;
p < 0.001 of normal) and LCAT +/ mice (65 and 59%;
p < 0.001 and 81%; not significant,
p = 0.17 of normal). In addition, plasma triglycerides
were significantly higher (212% of normal; p < 0.01)
in male homozygous knockout mice compared with wild-type animals but
remained normal in female knockout LCAT mice. Analyses of plasma
lipoproteins by fast protein liquid chromatography and two-dimensional
gel electrophoresis demonstrated the presence of heterogenous
pre -migrating HDL, as well as triglyceride-enriched very low density
lipoprotein. After 3 weeks on a high-fat high-cholesterol diet, LCAT
/ mice had significantly lower plasma concentrations of total
cholesterol, reflecting reduced levels of both proatherogenic apoB-containing lipoproteins as well as HDL, compared with controls. Thus, we demonstrate for the first time that the absence of LCAT attenuates the rise of apoB-containing lipoproteins in response to
dietary cholesterol. No evidence of corneal opacities or renal insufficiency was detected in 4-month-old homozygous knockout mice. The
availability of a homozygous animal model for human LCAT deficiency
states will permit further evaluation of the role that LCAT plays in
atherosclerosis as well as the feasibility of performing gene transfer
in human LCAT deficiency states.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. T. Flowers, A. K. Groen, A. T. Oler, M. P. Keller, Y. Choi, K. L. Schueler, O. C. Richards, H. Lan, M. Miyazaki, F. Kuipers, et al.
Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet
J. Lipid Res.,
December 1, 2006;
47(12):
2668 - 2680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cuchel and D. J. Rader
Macrophage Reverse Cholesterol Transport: Key to the Regression of Atherosclerosis?
Circulation,
May 30, 2006;
113(21):
2548 - 2555.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mezdour, G. Larigauderie, G. Castro, G. Torpier, J. Fruchart, M. Nowak, J.-C. Fruchart, M. Rouis, and N. Maeda
Characterization of a new mouse model for human apolipoprotein A-I/C-III/A-IV deficiency
J. Lipid Res.,
May 1, 2006;
47(5):
912 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Lewis and D. J. Rader
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Circ. Res.,
June 24, 2005;
96(12):
1221 - 1232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Namekata, Y. Enokido, I. Ishii, Y. Nagai, T. Harada, and H. Kimura
Abnormal Lipid Metabolism in Cystathionine {beta}-Synthase-deficient Mice, an Animal Model for Hyperhomocysteinemia
J. Biol. Chem.,
December 17, 2004;
279(51):
52961 - 52969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Webb, M. C. de Beer, B. F. Asztalos, N. Whitaker, D. R. van der Westhuyzen, and F. C. de Beer
Remodeling of HDL remnants generated by scavenger receptor class B type I
J. Lipid Res.,
September 1, 2004;
45(9):
1666 - 1673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Ng, C. Xie, G. F. Maguire, X. Zhu, F. Ugwu, E. Lam, and P. W. Connelly
Hypertriglyceridemia in Lecithin-cholesterol Acyltransferase-deficient Mice Is Associated with Hepatic Overproduction of Triglycerides, Increased Lipogenesis, and Improved Glucose Tolerance
J. Biol. Chem.,
February 27, 2004;
279(9):
7636 - 7642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rigotti, H. E. Miettinen, and M. Krieger
The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues
Endocr. Rev.,
June 1, 2003;
24(3):
357 - 387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Wiltshire, M. T. Pletcher, S. Batalov, S. W. Barnes, L. M. Tarantino, M. P. Cooke, H. Wu, K. Smylie, A. Santrosyan, N. G. Copeland, et al.
Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse
PNAS,
March 18, 2003;
100(6):
3380 - 3385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gautier, D. Masson, M. C. Jong, L. Duverneuil, N. Le Guern, V. Deckert, J.-P. P. de Barros, L. Dumont, A. Bataille, Z. Zak, et al.
Apolipoprotein CI Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (CETP) in CETP Transgenic/ApoCI-knocked Out Mice
J. Biol. Chem.,
August 23, 2002;
277(35):
31354 - 31363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-a. Wu, M. Tsujita, K. Okumura-Noji, S. Usui, H. Kakuuchi, M. Okazaki, and S. Yokoyama
Cholesteryl Ester Transfer Protein Expressed in Lecithin Cholesterol Acyltransferase-Deficient Mice
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2002;
22(8):
1347 - 1353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Feister, B. J. Auerbach, L. A. Cole, B. R. Krause, and S. K. Karathanasis
Identification of an IL-6 response element in the human LCAT promoter
J. Lipid Res.,
June 1, 2002;
43(6):
960 - 970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Furbee Jr., O. Francone, and J. S. Parks
In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice
J. Lipid Res.,
March 1, 2002;
43(3):
428 - 437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Furbee Jr., J. K. Sawyer, and J. S. Parks
Lecithin:Cholesterol Acyltransferase Deficiency Increases Atherosclerosis in the Low Density Lipoprotein Receptor and Apolipoprotein E Knockout Mice
J. Biol. Chem.,
January 25, 2002;
277(5):
3511 - 3519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Attie, J. P. Kastelein, and M. R. Hayden
Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis
J. Lipid Res.,
November 1, 2001;
42(11):
1717 - 1726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shike, S. Hirose, M. Kobayashi, K. Funabiki, T. Shirai, and Y. Tomino
Susceptibility and Negative Epistatic Loci Contributing to Type 2 Diabetes and Related Phenotypes in a KK/Ta Mouse Model
Diabetes,
August 1, 2001;
50(8):
1943 - 1948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tomimoto, M. Tsujita, M. Okazaki, S. Usui, T. Tada, T. Fukutomi, S. Ito, M. Itoh, and S. Yokoyama
Effect of Probucol in Lecithin-Cholesterol Acyltransferase-Deficient Mice : Inhibition of 2 Independent Cellular Cholesterol-Releasing Pathways In Vivo
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2001;
21(3):
394 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Escolà-Gil, J. Julve, A. Marzal-Casacuberta, J. Ordóñez-Llanos, F. González-Sastre, and F. Blanco-Vaca
ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance
J. Lipid Res.,
February 1, 2001;
42(2):
241 - 248.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. E. Rosenfeld, P. Polinsky, R. Virmani, K. Kauser, G. Rubanyi, and S. M. Schwartz
Advanced Atherosclerotic Lesions in the Innominate Artery of the ApoE Knockout Mouse
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2000;
20(12):
2587 - 2592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Escolà-Gil, J. Julve, A. Marzal-Casacuberta, J. Ordóñez-Llanos, F. González-Sastre, and F. Blanco-Vaca
Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia
J. Lipid Res.,
August 1, 2000;
41(8):
1328 - 1338.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. S. Parks, K. W. Huggins, A. K. Gebre, and E. R. Burleson
Phosphatidylcholine fluidity and structure affect lecithin:cholesterol acyltransferase activity
J. Lipid Res.,
April 1, 2000;
41(4):
546 - 553.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. W. Chisholm, A. K. Gebre, and J. S. Parks
Characterization of C-terminal histidine-tagged human recombinant lecithin:cholesterol acyltransferase
J. Lipid Res.,
August 1, 1999;
40(8):
1512 - 1519.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. J. M. van Vlijmen and J. Herz
Gene Targets and Approaches for Raising HDL
Circulation,
January 12, 1999;
99(1):
12 - 14.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Wang, T. Arai, Y. Ji, F. Rinninger, and A. R. Tall
Liver-specific Overexpression of Scavenger Receptor BI Decreases Levels of Very Low Density Lipoprotein ApoB, Low Density Lipoprotein ApoB, and High Density Lipoprotein in Transgenic Mice
J. Biol. Chem.,
December 4, 1998;
273(49):
32920 - 32926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Y. Hui
Utility and Importance of Gene Knockout Animals For Nutritional and Metabolic Research
J. Nutr.,
November 1, 1998;
128(11):
2052 - 2057.
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Carmeliet, L. Moons, and D. Collen
Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis
Cardiovasc Res,
July 1, 1998;
39(1):
8 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rigotti, B. L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger
A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism
PNAS,
November 11, 1997;
94(23):
12610 - 12615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lambert, N. Sakai, B. L. Vaisman, E. B. Neufeld, B. Marteyn, C.-C. Chan, B. Paigen, E. Lupia, A. Thomas, L. J. Striker, et al.
Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice
J. Biol. Chem.,
April 27, 2001;
276(18):
15090 - 15098.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|